Free shipping on all orders over $ 500

ABT-751

Cat. No. M1642

All AbMole products are for research use only, cannot be used for human consumption.

ABT-751 Structure
Synonym:

E7010

Size Price Availability Quantity
5mg USD 38 In stock
10mg USD 56 In stock
25mg USD 112 In stock
50mg USD 168 In stock
100mg USD 268 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

ABT-751 is an orally bioavailable tubulin inhibitor with IC50 of about 1.5 and 3.4 µM in neuroblastoma and non-neuroblastoma cell lines, respectively. ABT-751 had a broad spectrum of antitumor activity in a panel of 30 tumor cell lines in vitro and in xenograft models of human tumors in vivo, including gastric, colorectal, lung, and breast cancer models. ABT-751 showed antitumor activity against a broad spectrum of tumor lines including those resistant to conventional chemotherapies. A single dose of ABT-751 (30 mg/kg, intravenously) induced a rapid, transient reduction in tumor perfusion. After 1 h, tumor perfusion decreased by 57% before recovering to near pretreatment levels within 6 h. In contrast, ABT-751 produced little change in muscle perfusion at either time point. ABT-751, at concentrations corresponding to plasma levels achieved in vivo, caused endothelial cell retraction and significant loss of microtubules within 1 h.

Chemical Information
Molecular Weight 371.41
Formula C18H17N3O4S
CAS Number 141430-65-1
Solubility (25°C) DMSO ≥72 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Gaynon et al. J Pediatr Hematol Oncol. ABT-751 in Relapsed Childhood Acute Lymphoblastic Leukemia.

[2] Silver et al. J Vet Intern Med. Evaluation of the oral antimitotic agent (ABT-751) in dogs with lymphoma.

[3] Rudin et al. J Clin Oncol. Phase I/II study of pemetrexed with or without ABT-751 in advanced or metastatic non-small-cell lung cancer.

[4] Fox et al. Cancer Chemother Pharmacol. Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumors.

[5] Meany et al. Pediatr Blood Cancer. Clinical outcome in children with recurrent neuroblastoma treated with ABT-751 and effect of ABT-751 on proliferation of neuroblastoma cell lines and on tubulin polymerization in vitro.

Related Microtubule Products
Fosbretabulin disodium

Fosbretabulin disodium (Combretastatin A-4 phosphate) is a microtubule-targeting agent that binds β-tubulin with Kd of 0.4 μM.

Noscapine hydrochloride

Noscapine, a phthalideisoquinoline alkaloid constituting 1–10% of the alkaloid content of opium, has been used as a cough suppressant.

Triclabendazole

Triclabendazole is a benzimidazole, it binds to tubulin impairing intracellular transport mechanisms and interferes with protein synthesis. Triclabendazole induces gasdermin E (GSDME)-dependent pyroptosis by caspase-3 activation.

CYT997

CYT997 is a potent microtubule polymerization inhibitor with IC50 of 10-100 nM in cancer cell lines.

Vinflunine

Vinflunine (VFL) is a bifluorinated tubulin-targeted agent of the vinca alkaloids class active in advanced stage breast cancer.

  Catalog
Abmole Inhibitor Catalog




Keywords: ABT-751, E7010 supplier, Microtubule, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.